Red light therapy
Limited evidenceWhy it might help
Low-level laser and red or near-infrared light are proposed to modulate local inflammation and tendon-cell activity, which is why photobiomodulation has been trialled for painful shoulder tendons.
What the research shows
The Cochrane review of electrotherapy for rotator cuff disease found two placebo-controlled trials favouring low-level laser therapy for up to three weeks, but rated that evidence low quality, and found that adding laser to other physiotherapy produced few additional benefits across ten heterogeneous trials. A separate photobiomodulation review reported that subjective pain scores improved more often than objective measures such as range of motion. Short-term symptom relief is plausible; a change in the underlying tendon problem is not demonstrated.
Sources & what they found (2)
Electrotherapy modalities for rotator cuff disease (Cochrane systematic review) — PubMed / Cochrane Database of Systematic Reviews, 2016
Two placebo-controlled trials favoured low-level laser therapy up to three weeks, but on low-quality evidence, and adding it to other physiotherapy produced few extra benefits; pulsed electromagnetic field therapy 'may not provide clinically relevant benefits over placebo'.
Photobiomodulation as Medicine: Low-Level Laser Therapy (LLLT) for Acute Tissue Injury or Sport Performance Recovery — PMC / Journal of Functional Morphology and Kinesiology, 2024
Review concluding low-level laser therapy is 'of questionable utility for accelerating repair of deeper musculoskeletal structures in the setting of acute/sub-acute injury'; subjective scores improved more often than objective measures, and the primary evidence was rated low quality with no agreed dosing guidelines.



